Seres Therapeutics, Inc. Increase in Carrying Amount of Redeemable Preferred Stock
Seres Therapeutics, Inc. (MCRB) reported Increase in Carrying Amount of Redeemable Preferred Stock of $1.29 million for the 12-month period ending 2014-12-31, per its 10-K filed 2017-03-16.
Discontinued › Shareholders' Equity
us-gaap:IncreaseInCarryingAmountOfRedeemablePreferredStock · last filed 2017-03-16
- Seres Therapeutics, Inc. increase in carrying amount of redeemable preferred stock for fiscal 2014 was $1.29M.
| Period end | Increase in Carrying Amount of Redeemable Preferred Stock 12 month |
|---|---|
| 2014-12-31 | $1.29M 10-K · filed 2017-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |